Zim Laboratories Ltd (ZIMLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1000979,
    "name": "Zim Laboratories",
    "stock_name": "Zim Laboratories",
    "full_name": "Zim Laboratories Ltd",
    "name_url": "stocks-analysis/zim-laboratories",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "114.00",
    "chg": 5.35,
    "chgp": "4.92%",
    "dir": 1,
    "prev_price": "108.65",
    "mcapval": "584.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541400,
    "symbol": "ZIMLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE518E01015",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "82.62 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/zim-laboratories-1000979-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Zim Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-zim-laboratories-ltd-latest-results-good-or-bad-4001503",
        "imagepath": "",
        "date": "2026-05-20 19:24:06",
        "description": "Zim Laboratories Ltd's latest financial results for the fourth quarter of FY26 reveal significant operational challenges. The company reported a net profit of ₹3.74 crores, reflecting a year-on-year decline of 23.36%, while revenue stood at ₹105.27 crores, down 3.18% from the previous year. This revenue performance indicates a slight contraction, which is consistent with the broader trend of operational difficulties faced by the company.\n\nA notable concern is the operating profit before depreciation, interest, tax, and other income (PBDIT), which plummeted by 50.72% quarter-on-quarter to ₹7.19 crores. This resulted in an operating margin of 6.83%, a significant drop from 13.42% in the same quarter last year, highlighting severe pressures on profitability. The return on equity (ROE) was reported at a low 2.62%, indicating weak profitability relative to shareholder funds.\n\nThe financial data also shows that t..."
      },
      {
        "title": "Zim Laboratories Ltd Reports Stabilised Financial Trend Amid Mixed Quarterly Results",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zim-laboratories-ltd-reports-stabilised-financial-trend-amid-mixed-quarterly-results-3999994",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZimLaboratories_fintrenddot_3999994.png",
        "date": "2026-05-20 08:00:19",
        "description": "Zim Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, reported a flat financial performance for the quarter ended March 2026, marking a notable improvement from its previous negative trend. Despite challenges in profitability and non-operating income volatility, the company’s recent quarterly results indicate a stabilisation phase, with key metrics showing mixed signals against historical trends and broader market benchmarks."
      },
      {
        "title": "Zim Laboratories Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zim-laboratories-ltd-hits-upper-circuit-amid-strong-buying-pressure-3999225",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZimLaboratories_stocks_hitting_upper_circuit_3999225.png",
        "date": "2026-05-19 15:00:09",
        "description": "At Rs 102.28, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Zim Laboratories Ltd locked at its upper circuit of 5.0% on 19 May 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "When is the next results date for Zim Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-zim-laboratories-ltd-3990154",
        "imagepath": "",
        "date": "2026-05-13 23:17:15",
        "description": "The next results date for Zim Laboratories Ltd is scheduled for 19 May 2026...."
      },
      {
        "title": "Zim Laboratories Ltd Forms Golden Cross Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zim-laboratories-ltd-forms-golden-cross-signalling-potential-bullish-breakout-3989906",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZimLaboratories_goldencross_3989906.png",
        "date": "2026-05-13 18:01:45",
        "description": "The 50-day moving average for Zim Laboratories Ltd has crossed above the 200-day moving average, creating a golden cross on 13 Jun 2026. Yet, this technical milestone arrives amid a complex backdrop of mixed momentum indicators and a micro-cap profile, raising questions about the signal’s reliability."
      },
      {
        "title": "Zim Laboratories Ltd Valuation Shifts: Price Attractiveness Diminishes Amidst Sector Comparisons",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zim-laboratories-ltd-valuation-shifts-price-attractiveness-diminishes-amidst-sector-comparisons-3984706",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZimLaboratories_valuationdot_3984706.png",
        "date": "2026-05-11 08:02:20",
        "description": "Zim Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating, despite robust stock price gains and outperforming the broader market. This article analyses the recent changes in key valuation metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages and historical benchmarks, and assesses the implications for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Zim Laboratories Gains 9.62%: 2 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zim-laboratories-gains-962-2-key-factors-driving-the-weeks-momentum-3983211",
        "imagepath": "",
        "date": "2026-05-09 13:09:45",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Week opens at Rs.93.96 with steady volume</p>\n                    <p><strong>5 May:</strong> Technical momentum shifts amid mixed signals; stock closes at Rs.93.23 (-0.78%)</p>\n                    <p><strong>6 May:</strong> Investment rating upgraded to Sell; stock edges up to Rs.93.53 (+0.32%)</p>\n                    <p><strong>7 May:</strong> Price rallies 2.46% to Rs.95.83 on moderate volume</p>\n                    <p><strong>8 May:</strong> Sharp jump of 7.48% to Rs.103.00 on heavy volume</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>..."
      },
      {
        "title": "Zim Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zim-laboratories-ltd-is-rated-strong-sell-3962196",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ZimLaboratories_mojoScore_3962196.png",
        "date": "2026-04-25 10:10:14",
        "description": "Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 August 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis below presents the company’s current position as of 25 April 2026, incorporating the latest financial metrics, returns, and market data to provide investors with an up-to-date perspective."
      },
      {
        "title": "Zim Laboratories Ltd Falls to 52-Week Low of Rs 63 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zim-laboratories-ltd-stock-falls-to-52-week-low-of-rs63-3908168",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ZimLaboratories_priceRelatedfactors_3908168.png",
        "date": "2026-03-23 14:37:37",
        "description": "A sharp decline of 8.16% today dragged Zim Laboratories Ltd to a fresh 52-week low of Rs 63, extending its downward trajectory amid broader market weakness and company-specific concerns."
      }
    ],
    "total": 14,
    "sid": "1000979",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/zim-laboratories-1000979"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011",
      "datetime": "16-Jun-2026",
      "details": "The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dr Anwar Daud",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "15-Jun-2026",
      "details": "Disclosure under Regulation 30 of SEBI (LODR) 2015 with respect to schedule of Investor/ Analyst Meeting",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "13-Jun-2026",
      "details": "Please find enclosed the schedule of investor meet to be held on 17th June 2026 at 4:00 pm",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Zim Laboratories Ltd has declared <strong>5%</strong> dividend, ex-date: 19 Sep 19",
          "dt": "2019-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Zim Laboratories Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 22 Dec 22",
          "dt": "2022-12-22",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Zim Laboratories Ltd latest results good or bad?

2026-05-20 19:24:06

Zim Laboratories Ltd's latest financial results for the fourth quarter of FY26 reveal significant operational challenges. The company reported a net profit of ₹3.74 crores, reflecting a year-on-year decline of 23.36%, while revenue stood at ₹105.27 crores, down 3.18% from the previous year. This revenue performance indicates a slight contraction, which is consistent with the broader trend of operational difficulties faced by the company. A notable concern is the operating profit before depreciation, interest, tax, and other income (PBDIT), which plummeted by 50.72% quarter-on-quarter to ₹7.19 crores. This resulted in an operating margin of 6.83%, a significant drop from 13.42% in the same quarter last year, highlighting severe pressures on profitability. The return on equity (ROE) was reported at a low 2.62%, indicating weak profitability relative to shareholder funds. The financial data also shows that t...

Zim Laboratories Ltd Reports Stabilised Financial Trend Amid Mixed Quarterly Results

2026-05-20 08:00:19

Zim Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, reported a flat financial performance for the quarter ended March 2026, marking a notable improvement from its previous negative trend. Despite challenges in profitability and non-operating income volatility, the company’s recent quarterly results indicate a stabilisation phase, with key metrics showing mixed signals against historical trends and broader market benchmarks.

Zim Laboratories Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent

2026-05-19 15:00:09

At Rs 102.28, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Zim Laboratories Ltd locked at its upper circuit of 5.0% on 19 May 2026, with buyers queuing and no sellers willing to part with shares.

When is the next results date for Zim Laboratories Ltd?

2026-05-13 23:17:15

The next results date for Zim Laboratories Ltd is scheduled for 19 May 2026....

Zim Laboratories Ltd Forms Golden Cross Amid Mixed Technical Signals

2026-05-13 18:01:45

The 50-day moving average for Zim Laboratories Ltd has crossed above the 200-day moving average, creating a golden cross on 13 Jun 2026. Yet, this technical milestone arrives amid a complex backdrop of mixed momentum indicators and a micro-cap profile, raising questions about the signal’s reliability.

Zim Laboratories Ltd Valuation Shifts: Price Attractiveness Diminishes Amidst Sector Comparisons

2026-05-11 08:02:20

Zim Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating, despite robust stock price gains and outperforming the broader market. This article analyses the recent changes in key valuation metrics such as price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages and historical benchmarks, and assesses the implications for investors navigating the Pharmaceuticals & Biotechnology sector.

Zim Laboratories Gains 9.62%: 2 Key Factors Driving the Week’s Momentum

2026-05-09 13:09:45

Key Events This Week 4 May: Week opens at Rs.93.96 with steady volume 5 May: Technical momentum shifts amid mixed signals; stock closes at Rs.93.23 (-0.78%) 6 May: Investment rating upgraded to Sell; stock edges up to Rs.93.53 (+0.32%) 7 May: Price rallies 2.46% to Rs.95.83 on moderate volume 8 May: Sharp jump of 7.48% to Rs.103.00 on heavy volume Week Open...

Zim Laboratories Ltd is Rated Strong Sell

2026-04-25 10:10:14

Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 August 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis below presents the company’s current position as of 25 April 2026, incorporating the latest financial metrics, returns, and market data to provide investors with an up-to-date perspective.

Zim Laboratories Ltd Falls to 52-Week Low of Rs 63 as Sell-Off Deepens

2026-03-23 14:37:37

A sharp decline of 8.16% today dragged Zim Laboratories Ltd to a fresh 52-week low of Rs 63, extending its downward trajectory amid broader market weakness and company-specific concerns.

View All News